Kyle Fraser is an accomplished professional in the field of neuroscience, currently serving as the Director of Translational Sciences at Arvinas since June 2025. Prior to this role, Kyle held various positions at Biogen from July 2018 to June 2025, including Principal Scientist and Senior Scientist. Earlier experience includes a Postdoctoral Fellowship at Massachusetts General Hospital, focusing on the imaging of extracellular vesicles in glioblastoma patient liquid biopsies, and a Graduate Student role at the University of Alabama at Birmingham, where Kyle earned a PhD in Neuroscience. Kyle also holds a Bachelor's degree in Biomedical Sciences from Auburn University.
This person is not in any teams
This person is not in any offices